For 50 years, doctors shrugged about the disease running through Miranda Pappas’ family. Then she discovered something.

Gilead Sciences agreed to pay $45 million to settle allegations of paying kickbacks that improperly influenced prescriptions ...

As telehealth promotes GLP-1s for addiction, experts worry about fragmented care, and exposing patients to unknown risks.

Today, a look at FDA’s final guidance on drug-related apps and what it means for the future of digital therapeutics. Plus the ...

The surprising departure of Calley Means comes just before an election that may serve as a referendum on the MAHA movement.

This is the online version of Adam’s Biotech Scorecard, a weekly newsletter featuring exclusive, spicy analysis on the ...

A Moderna and Merck personalized mRNA cancer vaccine reduced the risk of disease recurrence in patients with melanoma by 42% ...

MAHA allies and nutrition experts want the Trump administration to act on ultra-processed foods before the elections.

Working-age U.S. adults without health insurance rose in 2026. Half of all uninsured people did not seek needed care because ...

U.S. is poised to issue a proposed rule that would subject outbound licensing deals with Chinese biotech companies to ...

An immune drug from Roivant could be headed to a new market, after the company reported positive trials in the eye disease ...

Jason is a general assignment reporter, with particular focus on genetic medicine and rare disease. Confidential tips can be sent on Signal at JasonMast.77. The scientists behind treating Baby KJ say ...